Balsm Alofoq Medical Co (SAU:9620) EBIT: ﷼2.59 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:9620 Balsm Alofoq Medical Co SAU:9620
24 GF Score
Price ﷼24.70
! 4 Warning Signs
View Full Analysis

What is Balsm Alofoq Medical Co EBIT?

Balsm Alofoq Medical Co SAU:9620 24 EBIT is ﷼2.59 Mil as of Dec. 2025. GuruFocus rates SAU:9620 with a GF Score™ of 24/100. The stock has 4 warning signs investors should review.

Balsm Alofoq Medical Co's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was ﷼1.13 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was ﷼2.59 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Balsm Alofoq Medical Co's annualized ROC % for the quarter that ended in Dec. 2025 was 7.38%. Balsm Alofoq Medical Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 13.45%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Balsm Alofoq Medical Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 4.94%.

Balsm Alofoq Medical Co  (SAU:9620) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Balsm Alofoq Medical Co's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=2.466 * ( 1 - 40.4% )/( (15.297 + 24.554)/ 2 )
=1.469736/19.9255
=7.38 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=34.331 - 0.93 - ( 18.104 - max(0, 1.278 - 22.692+18.104))
=15.297

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=35.649 - 0.251 - ( 10.844 - max(0, 2.008 - 20.605+10.844))
=24.554

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Balsm Alofoq Medical Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=2.256/( ( (11.639 + max(3.487, 0)) + (15.044 + max(3.379, 0)) )/ 2 )
=2.256/( ( 15.126 + 18.423 )/ 2 )
=2.256/16.7745
=13.45 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.385 + 3.275 + 0.881) - (0.93 + 0 + 0.124)
=3.487

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.699 + 3.564 + 0.897) - (0.251 + 0 + 1.53)
=3.379

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Balsm Alofoq Medical Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=2.591/52.420
=4.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Balsm Alofoq Medical Co EBIT Related Terms

Balsm Alofoq Medical Co EBIT Historical Data

* Premium members only.

The historical data trend for Balsm Alofoq Medical Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Balsm Alofoq Medical Co EBIT Chart

Balsm Alofoq Medical Co Annual Data
Trend Dec23 Dec24 Dec25
EBIT
4.40 5.17 2.59

Balsm Alofoq Medical Co Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
EBIT 0.00 1.52 3.65 1.46 1.13

SAU:9620 vs ABT, SYK, MDT: EBIT Comparison

For the Medical Devices subindustry, Balsm Alofoq Medical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Balsm Alofoq Medical Co EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Balsm Alofoq Medical Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Balsm Alofoq Medical Co's EV-to-EBIT falls into.


SAU:9620
24GF Score
Balsm Alofoq Medical Co SAU:9620
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Balsm Alofoq Medical Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was ﷼2.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ﷼2.59 Mil mean?
Balsm Alofoq Medical Co (SAU:9620) has a EBIT of ﷼2.59 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Balsm Alofoq Medical Co.
Is Balsm Alofoq Medical Co's EBIT too high?
Balsm Alofoq Medical Co's current EBIT is ﷼2.59 Mil. Overall, Balsm Alofoq Medical Co has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Balsm Alofoq Medical Co's EBIT compare to ABT and SYK?
Balsm Alofoq Medical Co's EBIT of ﷼2.59 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Balsm Alofoq Medical Co. Balsm Alofoq Medical Co's current EBIT is ﷼2.59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Balsm Alofoq Medical Co stock overvalued right now?
Balsm Alofoq Medical Co (SAU:9620) has a current EBIT of ﷼2.59 Mil. The current EBIT is ﷼2.59 Mil. Balsm Alofoq Medical Co's overall GF Score™ is 24/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Balsm Alofoq Medical Co (SAU:9620), the current EBIT is ﷼2.59 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Balsm Alofoq Medical Co Business Description

Address King Khalid Road, Qassim Region, Al-Ufuq District, Buraidah, SAU
Balsm Alofoq Medical Co operates in the medical sector. Its activities include medical services, specialized clinics and medical complexes, medical operations, and the import and supply of medical devices and supplies to all regions of the Kingdom of Saudi Arabia.
24GF Score

Get the complete analysis for SAU:9620

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼24.70
Price